Search

everythinglearnresearchcommunity

for

Search:↓

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Minoxidil is more effective than Latanoprost for treating patchy alopecia areata.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

IL-17 and certain immune cells are linked to more severe alopecia areata.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

Rosemary is as effective as Minoxidil for treating alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Adults with alopecia areata often have empty follicular openings, while children show more honeycomb pigment patterns.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Alopecia areata affects hair follicle structure, even in non-balding areas.

Almost half of the men with beard hair loss also developed scalp hair loss within a year.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

PRP and IT are equally effective for treating localized alopecia areata, but PRP causes more pain and bleeding.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Scalp biopsies are essential for diagnosing congenital alopecia areata.

A girl's hair loss was found to be caused by both a hair-pulling disorder and another hair loss condition.

Using 2.5 mg/mL triamcinolone acetonide is effective for hair growth in alopecia areata with fewer side effects.